Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COTL1 pseudogene 2 is a non-coding genomic sequence that resembles the COTL1 gene, which encodes coactosin-like protein 1, an actin-binding protein involved in cytoskeletal regulation. As a pseudogene, COTL1P2 does not encode a functional protein nor is it known to be involved in therapeutic targeting, biological pathways, or drug interactions. Its presence is mainly noted as a DNA sequence similar to a functional gene, and it may be referenced in genomic or evolutionary studies but has no known biological or pharmacological function. COTL1P2 (COTL1 pseudogene 2) is frequently found in gene databases as a sequence homologous to the functional COTL1 gene but is annotated as a pseudogene. The functional COTL1 gene is involved in cytoskeletal arrangement, actin binding, and leukotriene synthesis and is not the same as the pseudogene "COTL1 pseudogene 2". No evidence supports any druggability, biological activity, or disease relevance for COTL1P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COTL1 pseudogene 2 (COTL1P2).